This invention relates to novel compounds of Formula (I) to (VII), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
该发明涉及公式(I)到(VII)的新化合物,以及这些化合物的组合物,在治疗由
趋化因子白细胞介素-8(IL-8)介导的疾病状态中有用。